Novartis plans to acquire a majority share of Alcon for $39 billion in a two-part deal. First, Novartis and Nestle have reached an agreement under which Nestle will sell 74 million of its shares of Alcon to Novartis for about $11 billion. Then, Novartis has an exclusive option to purchase the remaining 52% share from Nestl? for $28 billion between Jan. 1, 2010, and July 31, 2011.
SUMMARY: Industry news and clinical reports covering the diagnosis, monitoring, and medical and surgical treatment of all ocular and visual disorders. Topics cover the full spectrum of eye care, from prescribing glasses and contact lenses to complex and delicate eye surgery. Disease conditions include cornea and external disease, glaucoma, neuro-ophthalmologic disorders, vitreoretinal diseases and infections.
Ophthalmology
Clinical Practice Tools
RSS Feeds
